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Abstract Health-related quality of life (HRQoL) is increas-
ingly recognized as a key outcome in both clinical and re-
search settings in the pediatric population with end-stage renal
disease (ESRD). This review aims to: (1) summarize the cur-
rent knowledge on HRQoL and socioprofessional outcomes
and (2) provide strategies for incorporation of HRQoL assess-
ment into clinical practice. Studies report that pediatric pa-
tients with ESRD have significantly lower HRQoL scores
compared with children with other chronic diseases. Patients
treated by dialysis are at particularly high risk for impaired
HRQoL. Furthermore, patients more often have impaired
neurocognitive functioning and lower academic achievement.
Important determinants of impaired HRQoL include medical
factors (i.e., receiving dialysis, disabling comorbidities, cos-
metic side effects, stunted growth), sociodemographic factors
(i.e., female gender, non-Western background) and psychoso-
cial factors (i.e., noneffective coping strategies). Contrary to
the situation in childhood, adult survivors of pediatric ESRD
report a normal mental HRQoL. Despite this subjective feel-
ing of well-being, these patients have on average experienced
significantly more difficulties in completing their education,
developing intimate relationships, and securing employment.
Several medical and psychosocial strategies may potentially
improve HRQoL in children with ESRD. Regular assessment
of HRQoL and neurocognitive functioning in order to identify
areas in which therapies and interventions may be required
should be part of standard clinical care.
Keywords End-stage renal disease . Health-related quality of
life . Neurocognitive functioning . Social outcomes . Renal
replacement therapy
Introduction
Medical and surgical advances have led to dramatic changes
in physical outcomes and substantial improvement in survival
rates for children with end-stage renal disease (ESRD) [1, 2].
Consequently, more children with ESRD are living with the
burden of long-term renal replacement therapy (RRT), a time-
consuming and invasive treatment that places high demands
on children and their families. Outcomes typically measured
in clinical trials include survival rates and biochemical and
physiological values. However, a focus on health-related qual-
ity of life (HRQoL) is needed to address the psychosocial
well-being of these children and to understand the impact of
the disease and its treatment on their lives.
HRQoL is therefore increasingly recognized as a key out-
come in both clinical and research settings in the pediatric
ESRD population [3–5].
Accurate measurement of HRQoL in children, however,
has proven to be complex, and different tools have been used
to this end. The purpose of our review is to give an overview
of knowledge on HRQoL, neurocognitive functioning, and
other social outcomes in pediatric ESRD patients (as assessed
by themselves and by their caregivers) and to provide strate-
gies for incorporation of HRQoL assessment into clinical
practice.
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Quality of life: concepts and measurement
instruments
Based on theWorld Health Organization’s definition, QoL has
been conceptualized as a multidimensional and subjective
construct that reflects an individual’s subjective assessment
of several domains of his or her life, including physical, social,
and psychological functioning [6]. It is a broad-ranging con-
cept affected in a complex way by the person's physical health,
psychological state, level of independence, social relation-
ships, and personal expectations. The restriction to HRQoL
refers to the inclusion of dimensions that are relevant to health
and are affected by ill health, such as dimensions of mobility,
pain, and psychosocial well-being [7].
Several different approaches have been reported to assess
HRQoL in the pediatric ESRD population, including health
status measurements that evaluate one or more health domains
[8–16] and qualitative methods [17, 18] (Table 1). Health
status measurements can be structured as either generic or
disease specific. Generic measures such as the Pediatric Qual-
ity of Life Inventory, version 4.0 ( PedsQL 4.0), the TACQOL
[TNO-AZL (Netherlands Organisation for Applied Scientific
Research Academic Medical Centre) Children's Quality Of
Life Questionnaire], and the Child Health and Illness
Profile-Adolescent Edition (CHIP-AE), are designed to assess
and compare the health status of patients with different dis-
eases and may provide valuable information for comparing
outcomes between sick and healthy populations. They are
generally well validated and reliable but are often not recom-
mended for work involving evaluation of randomized con-
trolled trials, as they lack sensitivity to detect small but clini-
cally significant changes over time or due to treatment for
specific diseases. Disease-specific measurements, like the
PedsQL ESRD 3.0, are more suitable to assess the impact of
a particular disease or treatment. These measures include
items that are likely to be affected by the specific disease
and are therefore more responsive to clinically significant
changes [5].
To assess the quality of HRQoL questionnaires, psychomet-
ric properties including reliability and validity are used. Reli-
ability refers to the degree to which an assessment tool produces
stable and consistent results and is measured by Cronbach’s α.
Measures with a Cronbach’s α ≥0.7 are considered sufficiently
reliable [23]. Even though none of the questionnaires used in the
pediatric ESRD population have specifically been validated in
this population, all questionnaires do fulfil these criteria based
on studies conducted in children with other chronic diseases
[19–22, 24, 25] (Table 1). Finally, more qualitative methods
(i.e., in-depth interviews and focus groups) have been used to
elicit in-depth and detailed insights about the impact of the
disease and treatment from the patient’s perspective, much of
which remain unspoken during clinical encounters. These
methods might expose issues that are not included in
questionnaires and therefore provide a broader scope patient
needs and feeling of well-being.
Measuring HRQoL in children is challenging. The relevant
domains of pediatric HRQoL questionnaires differ from those
in the adult population and need to be adjusted to the child’s
specific developmental age. Furthermore, a common method-
ological criticism on published pediatric HRQoL studies is the
use of a single informant, i.e., either caregiver or child. Obser-
vations of caregiver–child disagreement about HRQoL, par-
ticularly prominent in adolescent populations, have led to en-
dorsement of multi-informant ratings of HRQoL [26–28].
Other limitations with regard to HRQoL research are related
to the small sample sizes used in most studies. It is therefore
difficult to generalize findings to a larger population and to
undertake valid subgroup comparisons (i.e., based on medical
history, social economic status, etc.). Finally, most studies use
a cross-sectional design in which changes over time are not
assessed. Therefore, definite information about the effect of
time cannot be provided.
HRQoL in children with ESRD
A growing number of studies have assessed the impact of RRT
on the lives of children with ESRD [9, 10, 12, 13, 15, 17, 18,
29–34]. These children have to face several challenges, includ-
ing frequent hospitalization, painful medical procedures, school
absence, and restriction of activities. As a result, they are vul-
nerable to a multitude of short- and long-term academic, be-
havioral, and negative emotional outcomes, such as withdrawn
behavior. According to several studies conducted in both Eu-
rope and the USA, pediatric ESRD patients have significantly
lower HRQoL scores compared with healthy children of the
same age, especially concerning physical functioning in those
treated by dialysis [11–13, 29, 32, 35]. Furthermore, a study
from the USA of 2500 pediatric patients from ten different
physician-diagnosed disease clusters [36] found that patients
with ESRD had significantly worse HRQoL scores
compared to children with other chronic illnesses (including
diabetes, cardiac conditions, asthma, and severe obesity) on
the PedsQL 4.0 domains of physical health, psychological
health, social functioning, and school functioning.
Important determinants of HRQoL and proposed
interventions
Medical factors
As expected, the most important medical determinants asso-
ciated with impaired HRQoL in the pediatric ESRD popula-
tion are being on dialysis and the existence of comorbidities,
such as cardiovascular diseases, underlying syndromes,
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urological malformations, endocrinologic disorders, and gas-
trointestinal diseases [8, 10, 11, 29, 37]. Due to small number
of patients, most studies could not draw any conclusion about
the impact of individual comorbidities. However, in particular,
comorbidities that tend to represent an obstacle to social ac-
tivities, such as urological malformations leading to urinary
incontinence and the necessity of undergoing catheterization,
may be prone to negatively affect HRQoL [37, 38].
Studies report statistically significantly higher HRQoL
scores in children with a functioning renal graft, including
improved physical activity, greater satisfaction, less discom-
fort, and better school functioning [8, 13–16, 29, 34, 39, 40].
Some studies even report similar HRQoL scores in pediatric
patients with a renal transplant compared with the general
population [11, 16]. However, contrary to these high generic
scores, data from the disease-specific PedsQL 3.0 ESRDmod-
ule reveal significant specific problems among transplanted
children of all ages. These children reported a high level of
concern regarding physical appearance as well as problems
attributed to kidney issues (e.g., swelling, thirst, headache),
and they have more frequent school disruption and difficulties
with family and peer interaction [10, 13, 31]. Not surprisingly,
patients who experienced a rejection episode reported the
most physical discomfort [11]. The consequences of cosmetic
side effects of immunosuppressive therapy, such as weight
gain, gingival hypertrophy, acne, and cushingoid appearance
are important but underestimated problems in patients with a
functioning renal graft, particularly in the adolescent popula-
tion [29, 33, 41–44] (Table 2). Proposed strategies to mini-
mize the consequences of medication side effects and thereby
improve HRQoL include managing changes in appearance by
learning cosmetic application techniques and combating
weight gain through physical exercise [45].
In children undergoing dialysis, pronounced impairments
have been reported in the domains of physical health. Surpris-
ingly, most studies did not find significant differences in
HRQoL scores between patients on hemodialysis (HD) and
those on peritoneal dialysis (PD) [8, 9, 17]. It has been sug-
gested that this lack of difference could partly be linked to the
labor-intensive effort for the family associated with PD treat-
ment, which could somewhat invalidate the advantages of
more freedom and less disruption of daily life [46]. Contrary
to the equality of the (low) HRQoL scores in both dialysis
modalities, some studies have identified other advantages of
PD over HD, such as fewer dietary restrictionsand less disrup-
tion to home- and school-based activities [47, 48]. In addition,
authors of a qualitative study using in-depth interviews found
that pediatric patients perceived home HD to offer greater
flexibility and freedom to live a more normal life [18] com-
pared with patients receiving long-term hospital dialysis, who
indicated they felt imprisoned and were frustrated about the
restrictive and unrelenting dialysis schedule. In a study con-
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selected adolescents, and it improved their QoL and school
attendance but increased family burden [49]. Currently, pedi-
atric home HD programs are not readily available. This is
partly due to resource and logistic constraints but also because
they require a substantial commitment by the training center,
patient, and his or her family [50, 51]. A recent study suggests
that hospital-based nocturnal HDmight be another alternative,
as it can offer better uremia-associated outcomes, reduces di-
etary and fluid restrictions, and improved QoL and school
attendance [52].
Other medical factors associated with HRQoL scores in-
clude (final) height and hemoglobin level. In a Spanish study
of 81 pediatric ESRD patients, the authors found that shorter
patients reported lower self-esteem and lower satisfaction with
health [11]. In addition, a 2-year follow-up study [53] measured
the impact of short stature on HRQoL in 483 children with
chronic kidney disease (CKD) and revealed that height gains
and growth hormone use were associated with increases in
physical and social functioning, according to parent-proxy re-
port. Since recent data show that 43 % of patients with
childhood-onset ESRD do not achieve an adult height within
the normal range [54], there is certainly room for improvement
with respect to reducing the extent of stunted growth. Treatment
strategies shown to be effective in preventing growth retarda-
tion in patients with ESRD consist of correcting any nutritional,
water, and salt deficiencies and metabolic abnormalities, espe-
cially in young infants [55]. Also, recombinant growth hor-
mone (rhGH) therapy is safe and efficacious in children
[56]. However, a recent European study showed that in
several European countries, only a minority of children on
dialysis with short stature actually received rhGH, in contrast
to local policies [54]. Pediatric nephrologists should therefore
more vigorously implement these growth-stimulating thera-
pies in their management of children with ESRD.
Physicians should also pay sufficient attention to the cor-
rection of anemia. Parents of anemic children with CKD re-
ported worse HRQoL scores [57], and other studies found
lower physical functioning in anemic patients receiving
dialysis [58] or with a functioning transplant [11]. Correcting
anemia by administering erythropoietin and iron prepa-
rations may significantly improve long-term health out-
comes for children with kidney disease, resulting in improved
HRQoL [59, 60].
Sociodemographic factors
Female gender is associated with impaired HRQoL in the
pediatric ESRD population [9] (Table 2). Girls indicated more
often that they struggled emotionally and had concerns about
their appearance being negatively affected by their disease,
compared with their male counterparts. Surprisingly, neither
age at the time of investigation or at the start of RRT could be
associated in any waywith HRQoL scores in pediatric patients
with ESRD [10, 32, 36].
A study conducted in chi ldren with ESRD in
The Netherlands, Belgium, and part of Germany [35] found
that children of non-Western origin were at risk for impaired
HRQoL on emotional- and school-functioning domains. Also,
low parental level of education may result in a decreased
HRQoL in their children's childhood [61], and both patients
and parents being part of nonintact households reported lower
emotional HRQoL than those from married households [8].
Pediatric ESRD programs should therefore direct more atten-
tion in terms of psychosocial resources and interventions to
particularly vulnerable families (Table 2).
Psychosocial factors
Children with chronic illnesses use different coping strategies
to deal with stressors in relation to their disease [62]. It has been
suggested that by finding a way to incorporate the disease into
their daily lives, these children might be able to adjust to some
extent to their life-long chronic disease status. In the pediatric
ESRD population, a few important themes have been identi-
fied, such as obtaining knowledge, achieving a sense of nor-
mality, and gaining autonomy and empowerment in the treat-
ment [33]. Several studies conducted in the adolescent renal
transplant population indicate that patients desire comprehen-
sive information on technical, medical, and experimental as-
pects of surgery and posttransplant follow-up as well as on
the effect on their physical appearance and of alcohol, drugs,
and substance use on their disease [33, 34, 63, 64]. In addition,
a study examining experiences and perspectives of adolescents
waiting for a kidney transplant [18] identified strong apprehen-
sion about accepting a kidney from a living-related donor. The
benefits of kidney transplantations were recognized, but the
participants’ optimism was partly quelled by concerns about
the risks to their live donor in combination with the uncertainty
about transplant survival. Health care providers should ac-
knowledge these specific informational needs, and counselling
should be integrated into clinical care to address and allay fears
about kidney transplantation.
The overall lower HRQoL values among children receiv-
ing dialysis may reflect their sense of lack of control, social
isolation, poor self-esteem, perceived inability to gain inde-
pendence, uncertainties about their health and future, and life-
style restrictions attributable to the time-consuming and oner-
ous dialysis regimen [65]. An integrated clinic with ancillary
services that address sufficient school and psychosocial sup-
port are therefore recommended and might even result in bet-
ter clinical outcomes [66]. This also has important implica-
tions for transitional care, as the adult model of care may not
address cognitive, emotional, and social needs of young peo-
ple, and transition is often poorly coordinated. Furthermore, to
enhance empowerment and autonomy, we suggest shared
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decision-making processes in which patients are actively in-
volved in their own treatment decisions [67].
Studies also reveal the importance of social support in
terms of contact with fellow patients, as this would encourage
children to share their feelings, coping strategies, and personal
questions [17, 18]. Based on these findings, a community-
based young adult transplant service has been established in
Oxford, UK. This clinic involves a peer session facilitated by a
social worker and informal social activities, while the hospital
team provides an outreach medical service. Surveys conduct-
ed among participants showed that this provided a better en-
vironment for peer interaction and support, which resulted in a
higher clinical attendance rate, greater patient satisfaction and
engagement, and reduced episodes of late rejection [68]. Fur-
thermore, studies in adolescents with other chronic diseases
demonstrated the potential value of Internet-based programs
and mobile phone communication [69–71]. These results in-
dicate that contact with fellow patients, but also a greater sense
of self-management and access to information, could possibly
be delivered through innovative online initiatives.
Moreover, given current economic constraints and scarcity
of psychosocial services, it is particularly important to allocate
resources in a cost-effective manner. Consistent and rigorous
monitoring of HRQoL in children with ESRD might reveal
specific problems at an early phase, thereby preventing further
deterioration. In recent decades, there has been a growing in-
terest in patient-reported outcomes (PROs) as a tool for
pediatricians to use to discuss psychosocial issues dur-
ing medical consultation [72]. When pediatric psycholo-
gists and pediatricians work together, PROs can be used to
closely monitor children with chronic illnesses in a multidis-
ciplinary context, and referral to psychosocial interventions
can be better facilitated [73].
Neurocognitive status, educational attainment,
and social activities
Neurocognitive dysfunction is a well-recognized complica-
tion of pediatric ESRD. Many studies found evidence of sev-
eral neuropsychological deficits, including low scores for in-
telligence quotient (IQ), academic achievement, memory, and
executive functioning [74–76]. In a large North American
Study [Cronic Kidney Disease in Children (CKiD) of 386
children with CKD 2–4 (mean GFR 41), the overall
neurocognitive functioning was comparable with the general
population, but 21–40 % of participants scored at least one
standard deviation (SD) below the mean for IQ, aca-
demic achievement, attention regulation, or executive
functioning [77]. The risk of developmental delay may
be greatest for infants and young children on dialysis
therapy because infancy is a per iod of rap id
neurodevelopment, and approximately one half of brain
growth takes place during the first years of life [78–81].
Therefore, early intervention programs designed to im-
prove specific developmental areas, such as language
abilities and motor function, should be sought. The
neurodevelopmental status of older children and adoles-
cents on dialysis therapy has been characterized by ab-
normal performance on tasks of verbal abstract ability,
visual perceptual reasoning, memory, and visual motor
skills compared with healthy children and transplant re-
cipients [82]. It is therefore recommended that patients on
dialysis therapy have age-appropriate cognitive and achieve-
ment testing conducted on a regular basis, especially if prob-
lems with school achievement exist.
Not surprisingly, ESRD and its treatment often decrease
participation in peer and school-based activities. In a Turkish
cohort of 211 children with ESRD, 50 % of patients treated
with dialysis and 37.9 % of transplanted patients had left
school without grading because of their illness [14]. This is
in line with reports from the USA, where only 53% of patients
receiving HD were able to successfully achieve full-time
school attendance [83]. School attendance rates were higher
among transplanted patients; however, even in this group, the
impact of ESRD on academic functioning remained of partic-
ular concern for both patients and parents [9]. In addition,
prolonged absence from school due to treatment-related issues
can lead to a detrimental effect on sustaining peer relation-
ships, self-esteem, and academic achievement, which nega-
tively influences QoL [12, 15, 40, 84]. Therefore, regular
school attendance should be a primary outcome measure of
the overall success of RRT in children. Especially among
school-aged children treated by dialysis, there is a need for
strategies to optimize education opportunities. Dialysis units
could have on-site educators to complement school-based
teaching. There could be a close liaison with schools to offer
appropriate support in reducing school absenteeism to a min-
imum. As noted earlier, attention could also be paid to identi-
fying neurocognitive or behavioral abnormalities that may
have a significant negative impact on the likelihood of success
in the classroom. A psychologist-directed assessment can be
particularly helpful as a means of detecting specific learning
difficulties and targeting particular educational strategies [85].
Child versus parent-proxy scores
While the child’s self-report should be considered the standard
for measuring perceived HRQoL, there are circumstances,
such as young age of the patient (<5 years old) and cognitive
impairment, in which a child is unable to complete a HRQoL
instrument. In those cases, parent-proxy reports are mandato-
ry. Scores from parents are not only relevant as a substitute for
the child’s HRQoL perception, but they also provide a more
complete and comprehensive picture of the impact of the
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disease on the family. Second, they are important because it is
typically the parents’ perception of their child’s well-being
that influences health care use [86]. Therefore, using instru-
ments that measure both parent and child perspectives is rec-
ommended. However, studies reveal a statistically and clini-
cally significant discordance between parent and child
HRQoL scores, with patients reporting higher scores than
their caregivers [10, 87, 88]. Disagreement between parents’
and children's reports of HRQoL is, in itself, unlikely to indi-
cate that one of them is wrong or right, but rather is a conse-
quence of different beliefs about the child's health and well-
being. Due to their own grief about unfulfilled expectations
for their child and concerns regarding the (long-term) impact
of ESRD, parents may have a more negative view than their
children [89]. A recent meta-analysis regarding discrepancies
between child and parent-proxy HRQoL scores suggested that
the differences in scores also depends on the HRQoL domain
studied [86]. Parents tended to be more in agreement with
their children on objective physical domains but less so in
terms of emotional and social functioning and symptoms such
as pain, fatigue, and gastrointestinal complaints. Limited
knowledge due to respect for the child’s privacy and autono-
my may also be a factor accounting for the observed differ-
ences. In line with this hypothesis, a study in the UK among
428 pediatric patients with CKD and their parents [53]
showed that concordance between child and parent percep-
tions of HRQoL was age dependent, with a lower correlation
between self- and parent-proxy scores among adolescent pa-
tients compared with younger patients with ESRD. Obviously,
the parents’ own well-being may affect their perception of
their child’s HRQoL and symptoms. A poorer QoL, difficul-
ties in managing the child’s care, and higher levels of anxiety
and maladaptive behavior have been identified in parents of
children with ESRD [44, 90], which could result in a more
negative view regarding their child’s well-being. Therefore,
sufficient support for families should also be incorporated into
standard clinical care. This may prevent parent overprotective-
ness and may, as such, indirectly lead to better medical out-
comes and HRQoL in the child [91].
Children reaching adulthood
Few studies have reported on the effect of RRT in childhood
on HRQoL and social functioning in adulthood. According to
two studies [92, 93], adult patients with a functioning kidney
transplant achieve normal scores on self-assessment of psy-
chosocial and physical health. In a Dutch cohort study on the
long-term effects of renal insufficiency in children (LERIC)
we found that after 20–40 years of RRT [92], the proportion of
impaired HRQoL in transplanted patients was only higher for
the domain of general health perception when compared with
the aged-matched general population. Mental health of
transplanted patients was even significantly better than in the
general population. Equally good scores were found in an
Italian follow-up study on transplanted patients aged 18–34
years who were transplanted at a median age of 15 years [93].
Dialysis patients from the LERIC study more often had im-
paired scores compared with the general population for phys-
ical domains, but scores on mental domains were similar or
even better. Also, in young adults (median age 19.7, range
16.3–23.4 years) in the UK who survived severe CKD in
infancy, significantly lower scores on physical functioning
but similar scores on emotional well-being compared with
the age-matched general population were found [37]. These
high scores on emotional domains are in contrast with scores
from patients with adult-onset ESRD treated by dialysis who
reported substantially lower scores in the domains related to
mental HRQoL [94]. It has been suggested that this difference
could be directly related to a nearly life-long chronic disease
status: patients with a chronic disease since childhood may
have grown up with a lower perception of life than those
who acquired a chronic disease in adulthood. Consequently,
expectations regarding life of patients in the former group are
probably better met, despite physical disabilities.
In terms of social and professional outcomes, several studies
have shown that young adult survivors of childhood ESRD
struggle to secure gainful employment, complete their educa-
tion, experience intimate relationships, and live independently
[95–102]. A French study assessing 374 adult (aged 24–36)
survivors of pediatric transplantation found that professional
occupation was similar to the French general population but
the unemployment rate was higher: 18.5 % vs. 10.4 %;
P<0.01. This rate is comparable with findings in Dutch adults
with ESRD since childhood (19.4 % vs. 11.1 % in the healthy
population; P<0.01 [92]) and with findings from a German
study in 120 middle-aged survivors of pediatric ESRD
(14.0 % vs. 9.0 % in the healthy population; P<0.01) [101].
All studies found relatively lower educational attainment in
patients compared with the general population, which partly
explains the disadvantage in gaining employment. The LERIC
study also found that the low income rate (below national ave-
rage) was significantly higher in patients than in the general
population. Remarkably, the study conducted in the UK among
adolescent survivors of severe CKD in infancy found an unem-
ployment rate comparable with the general population (17 %
vs. 16.2 %) [37]. The discrepancy with the French and Dutch
data might be partly explained by the younger age at time of
investigation in our cohort. As a consequence, the majority of
patients were still studying, and only 24 % had a paid job.
Conclusion and recommendations
ESRD and its treatment have a severe impact on the HRQoL
of children, as it affects both physical and emotional
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functioning and interferes with normal daily life. In particular,
patients on dialysis are at high risk for impaired HRQoL.
Regular assessment of HRQoL, including implementation of
patient-reported outcomes, should therefore become part of
the standard care in order to identify specific areas for inter-
ventions. Potential effective medical and psychosocial strate-
gies are known to improve HRQoL, but more attention must
be paid to implementing these strategies. Medically, more ef-
fort must be put into implementing treatment regimens that
reduce cosmetic side effects and the poor growth rate in chil-
dren with ESRD. Where the possibility of a successful renal
transplant is unlikely, a home HD program that can reduce
dietary and fluid restriction and improve freedom and auton-
omy should be actively explored. Several psychological inter-
ventions and initiatives exist that may stimulate such chil-
dren’s ability to cope with ESRD and its treatment by provid-
ing capacity and encouraging confidence to manage their own
health, participate in social activities, progress in their studies,
and remain vigilant in dialysis and posttransplant treatment
responsibilities. All studies advocate a multidisciplinary
patient-centered approach that promotes shared decision mak-
ing, control, and self-efficacy in treatment management and
educational and vocational opportunities.
Furthermore, several neurocognitive problems, including
deficits in IQ, academic achievement, and executive function-
ing, have been reported in the pediatric ESRD population.
Especially for children on dialysis, it is recommended to con-
duct age-appropriate cognitive and achievement testing on a
regular basis. Dialysis units should have on-site educators to
complement school-based teaching.
In the long term, adult survivors of pediatric ESRD have
impaired physical but encouragingly good mental HRQoL.
However, they do experience more difficulties integrating into
the working population and building a social and family life.
Research agenda
Large multicenter and longitudinal studies are warranted to
ensure adequate sample size and statistical power to better
elucidate changes over time in HRQoL outcomes, to investi-
gate which patient factors (i.e., medical, sociodemographic,
and psychosocial) may be related to such change, and to fur-
ther assess which interventional targets would be most suit-
able. The implementation of patient-reported outcomes might
be a feasible platform to closely monitor HRQoL outcomes
over time. Studies should use both generic and disease-
specific questionnaires and obtain information from both pa-
tients and parents in order to generate the most comprehensive
outcomes. Furthermore, a utility-based approach has recently
been used to assess QoL among (pediatric) ESRD patients.
This construct assesses the relative desirability of health states
and forms the basis of the quality-adjusted life year (QALY)
analysis, commonly used by health economists in decision-
and cost-effectiveness studies. This approach is a promising
addition to the existing health status measurements.
However, since these questionnaires have only been
used in a few studies among pediatric ESRD patients, further
research is required to assess their validity and reliability in
this specific population.
Future research should focus not only on evaluating
the effect of the proposed interventions longitudinally
on HRQoL but also on relevant medical outcomes, such
as adherence, biochemical control, and graft survival, thererby
acknowledging the difficulties of such studies with so many
co-variables.
Key summary points
1. ESRD in children affects physical and emotional func-
tioning, with an adverse impact on HRQoL and
neurocognitive functioning, especially for patients receiv-
ing dialysis.
2. Determinants of impaired HRQoL include medical,
sociodemographic, and psychosocial factors.
3. Rigorous monitoring of HRQoL and cognitive testing
might reveal specific problems at an early stage, facilitat-
ing appropriate interventions.
4. Implementation of treatment regimens that reduce cos-
metic side effects and poor growth should be pursued.
5. Psychosocial interventions are warranted to stimulate
coping strategies to give children the capacity and
confidence to manage, and gradually take responsi-
bility for, their own health, as well as progressing in
their studies and participat ing in the wider
community.
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Questions (Answers are provided following
the reference list)
1. According to the current literature, the overall HRQoL of




(d) No sufficient evidence
2. Which medical factor has not been associated with im-
paired HRQoL?
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(a) Final height
(b) Side effects of immunosuppressive regimen
(c) Level of serum hemoglobin
(d) Level of serum urea
3. Compared with parent-proxy HRQoL scores, patients
report:
(a) Higher HRQoL scores
(b) Lower HRQoL scores
(c) Comparable HRQoL scores
(d) Scores are never obtained from both patients and
caregivers
4. Which statement is true regarding sufficient support of
adolescent patients?
(a) Adolescent patients should be consciously checked
and overheard to prevent them from not following
medical recommendations
(b) Adolescent patients should be encouraged tomanage
their own health and to take responsibility in their
treatment
(c) Adolescent patients often do not want to share
their experiences and coping strategies with
other patients
(d) Adolescent patients should not be informed about
risk-taking behaviors, as this could make such be-
haviors more likely to be attempted
5. The risk for developmental delay regarding neurocognitive






6. Adult survivors of pediatric ESRD report:
(a) High scores on both emotional and physical HRQoL
domains
(b) Low scores on both emotional and physical HRQoL
domains
(c) High scores on emotional domains but low scores on
physical HRQoL domains
(d) Low scores on emotional domains but high scores on
physical HRQoL domains
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